v3.25.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 27, 2025
Sep. 28, 2024
Current assets:    
Cash and cash equivalents $ 882,488 $ 753,550
Restricted cash 15,945 14,853
Accounts receivable, net 325,297 326,220
Inventories, net 722,106 757,943
Prepaid expenses and other 30,294 34,240
Total current assets 1,976,130 1,886,806
Plant, property and equipment, net 363,188 379,166
Goodwill 554,692 551,361
Other intangible assets, net 447,643 473,280
Operating lease right-of-use assets 222,863 205,137
Other assets 61,127 57,689
Total 3,625,643 3,553,439
Current liabilities:    
Accounts payable 234,618 212,606
Accrued expenses 247,213 245,226
Current lease liabilities 56,865 57,313
Current portion of long-term debt 62 239
Total current liabilities 538,758 515,384
Long-term debt 1,191,641 1,189,809
Long-term lease liabilities 191,739 173,086
Deferred income taxes and other long-term obligations 118,572 117,615
Commitments and contingencies (Note 12)
Equity:    
Additional paid-in capital 571,392 598,098
Retained earnings 1,015,096 959,511
Accumulated other comprehensive loss (3,849) (2,626)
Total Central Garden & Pet shareholders’ equity 1,583,268 1,555,654
Noncontrolling interest 1,665 1,891
Total equity 1,584,933 1,557,545
Total 3,625,643 3,553,439
Common stock ($0.01 par value; 80 million shares authorized; 9,650,221 and 11,074,620 outstanding at September 27, 2025 and September 28, 2024, respectively)    
Equity:    
Common stock ($0.01 par value; 80 million shares authorized; 9,650,221 and 11,074,620 outstanding at September 27, 2025 and September 28, 2024, respectively) 97 111
Class A common stock ($0.01 par value; 100 million shares authorized; 51,618,682 and 54,446,194 outstanding at September 27, 2025 and September 28, 2024, respectively)    
Equity:    
Common stock ($0.01 par value; 80 million shares authorized; 9,650,221 and 11,074,620 outstanding at September 27, 2025 and September 28, 2024, respectively) 516 544
Class B stock ($0.01 par value; 3 million shares authorized; 1,602,374 and 1,602,374 outstanding at September 27, 2025 and September 28, 2024, respectively)    
Equity:    
Common stock ($0.01 par value; 80 million shares authorized; 9,650,221 and 11,074,620 outstanding at September 27, 2025 and September 28, 2024, respectively) $ 16 $ 16

Source

HTML PDF
ZIP